MedPath

Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2007-01-01
Employees
302
Market Cap
-
Website
http://www.dicerna.com

Clinical Trials

22

Active:17
Completed:1

Trial Phases

2 Phases

Phase 1:18
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials

Phase 1
18 (94.7%)
Phase 3
1 (5.3%)

A Natural History Study of Patients with Genetically Confirmed Primary Hyperoxaluria Type 3 with a History of Stone Events

Not yet recruiting
Conditions
Primary Hyperoxaluria type 3
N/A
Last Posted Date
2024-08-19
Lead Sponsor
Dicerna Pharmaceuticals, Inc.
Target Recruit Count
1
Registration Number
LBCTR2021054742

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.